《港股》恆指收跌18點 理想午後抽高近10% 醫藥股受捧
阿思達克 07-17 16:38
港股先升後回，恆指高開29點，初段升154點一度高見24,672點後回落，曾倒跌69點見24,447點。全日跌18點或0.08%，收24,498點；國指跌8點或0.1%，收8,853點；恆生科技指數升30點或0.6%，收5,448點。大市全日成交總額2,364.12億元。
京東外賣把「超時20分鐘免單」改為「準時寶」服務，京東(09618.HK)及阿里(09988.HK)跌0.2%及1.1%，美團(03690.HK)升1.1%。百度(09888.HK)上線主打無廣告智能搜索「TizzyAI」，股價跌3.3%。嗶哩嗶哩(09626.HK)獲美銀證券上調目標價，股價升2%。其他科技股方面，騰訊(00700.HK)升0.1%報517元，網易(09999.HK)升0.6%，快手(01024.HK)跌0.6%。此外，中軟(00354.HK)及地平線(09660.HK)升12.7%及4.9%，新東方(09901.HK)跌2.5%，藍思科技(06613.HK)升8.1%。晶片股中芯(00981.HK)及華虹(01347.HK)升2%。
車股方面，理想(02015.HK)i8開啟預訂，售價35萬至40萬人幣，理想股價炒高9.7%收124.1元，成交額49.4億元。小鵬匯天飛行汽車工廠封頂，計劃下季竣工明年交付，小鵬(09868.HK)升1.1%。小米(01810.HK)跌2%，比亞迪(01211.HK)及吉利(00175.HK)升1.1%及4.2%。鋰業股贛鋒(01772.HK)及天齊(09696.HK)升5%及4.4%。
醫藥股炒高，摩通指第11批全國藥品集中採購透明度更高及降價溫和，料對製藥公司影響減弱。藥明巨諾(02126.HK)升20.7%，復旦張江(01349.HK)及開拓藥業(09939.HK)升14.3%及11%，康方(09926.HK)及百濟神州(06160.HK)升逾10%，三生製藥(01530.HK)及金斯瑞(01548.HK)升9.5%及8.2%。中生製藥(01177.HK)升5.9%，藥明生物(02269.HK)及翰森(03692.HK)升4.4%及4%。
金融股方面，匯控(00005.HK)及港交所(00388.HK)升0.5%及0.6%，友邦(01299.HK)跌0.4%，渣打(02888.HK)升1.9%。國泰君安國際(01788.HK)跌0.2%，成交逾43億元。金礦股招金(01818.HK)及山東黃金(01787.HK)跌2.8%及3.8%，靈寶(03330.HK)跌5.2%。
其他股份方面，深交所將海天味業(03288.HK)調入港股通標的證券名單，海天味業倒跌2.5%。據報新世界(00017.HK)擬放售機場購物中心11 Skies，新世界升1.7%。非凡領越(00933.HK)斥資4.5億再增持李寧(02331.HK)，最新持股12.34%，非凡領越升5.1%，李寧(02331.HK)升1%。多點數智(02586.HK)折讓一成先舊後新配股淨籌3.89億元，復牌股價跌4.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
